Suppr超能文献

长链非编码 RNA 转移相关肺腺癌转录本 1 在心力衰竭中脂质代谢和炎症中的作用机制。

Mechanism of long non‑coding RNA metastasis‑associated lung adenocarcinoma transcript 1 in lipid metabolism and inflammation in heart failure.

机构信息

Department of Cardiology I, Yantai Yuhuangding Hospital, Yantai, Shandong 264000, P.R. China.

Department of Cardiac Surgery ICU, Yantai Yuhuangding Hospital, Yantai, Shandong 264000, P.R. China.

出版信息

Int J Mol Med. 2021 Mar;47(3). doi: 10.3892/ijmm.2020.4838. Epub 2021 Jan 15.

Abstract

Heart failure (HF) is a serious threat to human health. Long noncoding RNAs (lncRNAs) are critical regulators of HF. The aim of the study was to investigate the molecular mechanism of MALAT1 in HF rats. MALAT1 expression was detected in serum of normal volunteers and HF patients, HF rats and isoproterenol (ISO)‑induced H9C2 cells, and its diagnostic value was evaluated in HF patients. Indexes related to cardiac functions and hemodynamics, myocardial injury, lipid metabolism, lipid oxidation, and inflammation were detected. Moreover, the downstream mechanism of MALAT1 was predicted and verified and experiments were further performed in ISO‑induced H9C2 cells to verify the effects of MALAT1 in HF. MALAT1 was highly expressed in serum of HF patients, HF rats and ISO‑induced H9C2 cells and was valuable in predicting HF. Inhibition of MALAT1 increased cardiac function and anti‑inflammation and alleviated myocardial injury, lipid metabolism, lipid oxidation and apoptosis rates. Inhibition of MALAT1 reduced H9C2 cell injury. MALAT1 competitively bound to microRNA (miR)‑532‑3p to upregulate LDLR protein. Inhibition of miR‑532‑3p weakened the protective effect of downregulated MALAT1 against H9C2 cell injury. We concluded that MALAT1 upregulated LDLR expression by competitively binding to miR‑532‑3p, thereby increasing pathological injury in HF.

摘要

心力衰竭(HF)是严重威胁人类健康的疾病。长链非编码 RNA(lncRNA)是 HF 的关键调控因子。本研究旨在探讨 MALAT1 在 HF 大鼠中的分子机制。检测了正常志愿者和 HF 患者、HF 大鼠和异丙肾上腺素(ISO)诱导的 H9C2 细胞血清中的 MALAT1 表达,并评估了其在 HF 患者中的诊断价值。检测了与心功能和血流动力学、心肌损伤、脂质代谢、脂质氧化和炎症相关的指标。此外,还预测和验证了 MALAT1 的下游机制,并在 ISO 诱导的 H9C2 细胞中进一步进行了实验,以验证 MALAT1 在 HF 中的作用。MALAT1 在 HF 患者、HF 大鼠和 ISO 诱导的 H9C2 细胞血清中高表达,对预测 HF 有价值。抑制 MALAT1 可增加心脏功能和抗炎作用,并减轻心肌损伤、脂质代谢、脂质氧化和凋亡率。抑制 MALAT1 可减轻 H9C2 细胞损伤。MALAT1 与 microRNA(miR)-532-3p 竞争性结合,上调 LDLR 蛋白。抑制 miR-532-3p 减弱了下调 MALAT1 对 H9C2 细胞损伤的保护作用。综上所述,MALAT1 通过与 miR-532-3p 竞争性结合而上调 LDLR 表达,从而增加 HF 中的病理损伤。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12a6/7834958/471b8eb68ecf/IJMM-47-03-4838-g00.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验